nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.115	0.185	CbGbCtD
Ondansetron—CYP3A7—Ifosfamide—germ cell cancer	0.115	0.185	CbGbCtD
Ondansetron—CYP3A5—Ifosfamide—germ cell cancer	0.0865	0.139	CbGbCtD
Ondansetron—CYP2C9—Ifosfamide—germ cell cancer	0.058	0.0929	CbGbCtD
Ondansetron—CYP2E1—Etoposide—germ cell cancer	0.0532	0.0852	CbGbCtD
Ondansetron—CYP3A5—Etoposide—germ cell cancer	0.0414	0.0662	CbGbCtD
Ondansetron—CYP3A4—Ifosfamide—germ cell cancer	0.0337	0.054	CbGbCtD
Ondansetron—CYP1A2—Etoposide—germ cell cancer	0.0308	0.0493	CbGbCtD
Ondansetron—CYP2C9—Cisplatin—germ cell cancer	0.0282	0.0452	CbGbCtD
Ondansetron—CYP2D6—Vinblastine—germ cell cancer	0.0282	0.0451	CbGbCtD
Ondansetron—CYP3A4—Vinblastine—germ cell cancer	0.0179	0.0286	CbGbCtD
Ondansetron—HTR3A—fourth ventricle—germ cell cancer	0.0171	0.0902	CbGeAlD
Ondansetron—HTR1B—dura mater—germ cell cancer	0.0167	0.088	CbGeAlD
Ondansetron—CYP3A4—Etoposide—germ cell cancer	0.0161	0.0258	CbGbCtD
Ondansetron—HTR3A—myenteric nerve plexus—germ cell cancer	0.012	0.0632	CbGeAlD
Ondansetron—CYP2C9—cardial valve—germ cell cancer	0.0103	0.0542	CbGeAlD
Ondansetron—HTR3A—vagus nerve—germ cell cancer	0.00798	0.0422	CbGeAlD
Ondansetron—HTR1B—trigeminal nerve—germ cell cancer	0.00716	0.0378	CbGeAlD
Ondansetron—HTR3A—cranial nerve—germ cell cancer	0.00608	0.0321	CbGeAlD
Ondansetron—HTR1B—cranial nerve—germ cell cancer	0.0051	0.027	CbGeAlD
Ondansetron—OPRM1—telencephalic ventricle—germ cell cancer	0.00453	0.0239	CbGeAlD
Ondansetron—HTR4—telencephalon—germ cell cancer	0.0044	0.0232	CbGeAlD
Ondansetron—HTR1B—telencephalic ventricle—germ cell cancer	0.00415	0.0219	CbGeAlD
Ondansetron—HTR4—pituitary gland—germ cell cancer	0.00358	0.0189	CbGeAlD
Ondansetron—HTR1A—telencephalic ventricle—germ cell cancer	0.00335	0.0177	CbGeAlD
Ondansetron—HTR4—adrenal gland—germ cell cancer	0.0032	0.0169	CbGeAlD
Ondansetron—HTR3A—ganglion—germ cell cancer	0.00308	0.0163	CbGeAlD
Ondansetron—OPRM1—ganglion—germ cell cancer	0.00282	0.0149	CbGeAlD
Ondansetron—HTR1B—ganglion—germ cell cancer	0.00258	0.0136	CbGeAlD
Ondansetron—CYP1A2—urine—germ cell cancer	0.00233	0.0123	CbGeAlD
Ondansetron—CYP2C9—urine—germ cell cancer	0.00221	0.0117	CbGeAlD
Ondansetron—CYP2E1—urine—germ cell cancer	0.0021	0.0111	CbGeAlD
Ondansetron—HTR1A—ganglion—germ cell cancer	0.00208	0.011	CbGeAlD
Ondansetron—SLC47A2—head—germ cell cancer	0.00208	0.011	CbGeAlD
Ondansetron—HTR1B—blood vessel—germ cell cancer	0.00205	0.0108	CbGeAlD
Ondansetron—HTR4—brain—germ cell cancer	0.00198	0.0105	CbGeAlD
Ondansetron—CYP3A4—urine—germ cell cancer	0.00169	0.00891	CbGeAlD
Ondansetron—CYP2D6—urine—germ cell cancer	0.00166	0.00877	CbGeAlD
Ondansetron—HTR3A—trigeminal ganglion—germ cell cancer	0.00151	0.00799	CbGeAlD
Ondansetron—SLC47A2—brain—germ cell cancer	0.0015	0.00794	CbGeAlD
Ondansetron—SLC47A1—trigeminal ganglion—germ cell cancer	0.00149	0.00785	CbGeAlD
Ondansetron—HTR3A—brainstem—germ cell cancer	0.00134	0.00707	CbGeAlD
Ondansetron—SLC47A1—brainstem—germ cell cancer	0.00131	0.00694	CbGeAlD
Ondansetron—SLC47A1—eye—germ cell cancer	0.00128	0.00676	CbGeAlD
Ondansetron—HTR1B—trigeminal ganglion—germ cell cancer	0.00127	0.0067	CbGeAlD
Ondansetron—OPRM1—brainstem—germ cell cancer	0.00123	0.00648	CbGeAlD
Ondansetron—HTR3A—telencephalon—germ cell cancer	0.00119	0.00627	CbGeAlD
Ondansetron—HTR1B—brainstem—germ cell cancer	0.00112	0.00593	CbGeAlD
Ondansetron—SLC47A1—decidua—germ cell cancer	0.00111	0.00584	CbGeAlD
Ondansetron—OPRM1—telencephalon—germ cell cancer	0.00109	0.00575	CbGeAlD
Ondansetron—CYP3A7—endocrine gland—germ cell cancer	0.00106	0.00559	CbGeAlD
Ondansetron—HTR1B—telencephalon—germ cell cancer	0.000996	0.00526	CbGeAlD
Ondansetron—SLC47A1—gonad—germ cell cancer	0.000973	0.00514	CbGeAlD
Ondansetron—SLC47A1—uterus—germ cell cancer	0.000967	0.00511	CbGeAlD
Ondansetron—SLC47A1—pituitary gland—germ cell cancer	0.00095	0.00502	CbGeAlD
Ondansetron—SLC47A1—medulla oblongata—germ cell cancer	0.000916	0.00484	CbGeAlD
Ondansetron—KCNH2—trigeminal ganglion—germ cell cancer	0.000911	0.00481	CbGeAlD
Ondansetron—HTR1A—brainstem—germ cell cancer	0.000906	0.00478	CbGeAlD
Ondansetron—Dysuria—Ifosfamide—germ cell cancer	0.000868	0.0048	CcSEcCtD
Ondansetron—SLC47A1—adrenal gland—germ cell cancer	0.000848	0.00448	CbGeAlD
Ondansetron—Hypokalaemia—Cisplatin—germ cell cancer	0.000843	0.00466	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.000834	0.00462	CcSEcCtD
Ondansetron—Ill-defined disorder—Vinblastine—germ cell cancer	0.000832	0.0046	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.000821	0.00454	CcSEcCtD
Ondansetron—SLC47A1—spinal cord—germ cell cancer	0.000817	0.00432	CbGeAlD
Ondansetron—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.000816	0.00452	CcSEcCtD
Ondansetron—Myocardial infarction—Ifosfamide—germ cell cancer	0.000812	0.00449	CcSEcCtD
Ondansetron—Malaise—Vinblastine—germ cell cancer	0.000808	0.00447	CcSEcCtD
Ondansetron—Flushing—Bleomycin—germ cell cancer	0.000807	0.00447	CcSEcCtD
Ondansetron—HTR1A—telencephalon—germ cell cancer	0.000804	0.00425	CbGeAlD
Ondansetron—SLC47A1—female gonad—germ cell cancer	0.000791	0.00418	CbGeAlD
Ondansetron—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000783	0.00433	CcSEcCtD
Ondansetron—OPRM1—midbrain—germ cell cancer	0.000782	0.00413	CbGeAlD
Ondansetron—Chills—Bleomycin—germ cell cancer	0.00078	0.00432	CcSEcCtD
Ondansetron—Convulsion—Vinblastine—germ cell cancer	0.000777	0.0043	CcSEcCtD
Ondansetron—Erythema multiforme—Dactinomycin—germ cell cancer	0.000767	0.00424	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000764	0.00423	CcSEcCtD
Ondansetron—OPRM1—spinal cord—germ cell cancer	0.000763	0.00403	CbGeAlD
Ondansetron—Erythema—Bleomycin—germ cell cancer	0.000757	0.00419	CcSEcCtD
Ondansetron—Bradycardia—Ifosfamide—germ cell cancer	0.000757	0.00419	CcSEcCtD
Ondansetron—Discomfort—Vinblastine—germ cell cancer	0.000754	0.00417	CcSEcCtD
Ondansetron—Flushing—Dactinomycin—germ cell cancer	0.000753	0.00417	CcSEcCtD
Ondansetron—Haemoglobin—Ifosfamide—germ cell cancer	0.000747	0.00413	CcSEcCtD
Ondansetron—Haemorrhage—Ifosfamide—germ cell cancer	0.000743	0.00411	CcSEcCtD
Ondansetron—HTR3A—head—germ cell cancer	0.000739	0.00391	CbGeAlD
Ondansetron—SLC47A1—endocrine gland—germ cell cancer	0.000736	0.00389	CbGeAlD
Ondansetron—Chills—Dactinomycin—germ cell cancer	0.000728	0.00403	CcSEcCtD
Ondansetron—SLC47A1—head—germ cell cancer	0.000726	0.00384	CbGeAlD
Ondansetron—Bronchospasm—Etoposide—germ cell cancer	0.000721	0.00399	CcSEcCtD
Ondansetron—Visual impairment—Ifosfamide—germ cell cancer	0.000716	0.00396	CcSEcCtD
Ondansetron—KCNH2—telencephalon—germ cell cancer	0.000716	0.00378	CbGeAlD
Ondansetron—HTR1B—midbrain—germ cell cancer	0.000715	0.00378	CbGeAlD
Ondansetron—Erythema—Dactinomycin—germ cell cancer	0.000706	0.00391	CcSEcCtD
Ondansetron—Acute coronary syndrome—Cisplatin—germ cell cancer	0.000704	0.00389	CcSEcCtD
Ondansetron—Erythema multiforme—Ifosfamide—germ cell cancer	0.000703	0.00389	CcSEcCtD
Ondansetron—Ill-defined disorder—Bleomycin—germ cell cancer	0.000703	0.00389	CcSEcCtD
Ondansetron—SLC47A1—testis—germ cell cancer	0.000702	0.00371	CbGeAlD
Ondansetron—Myocardial infarction—Cisplatin—germ cell cancer	0.0007	0.00387	CcSEcCtD
Ondansetron—HTR1B—spinal cord—germ cell cancer	0.000698	0.00369	CbGeAlD
Ondansetron—Eye disorder—Ifosfamide—germ cell cancer	0.000695	0.00384	CcSEcCtD
Ondansetron—Cardiac disorder—Ifosfamide—germ cell cancer	0.00069	0.00382	CcSEcCtD
Ondansetron—Flushing—Ifosfamide—germ cell cancer	0.00069	0.00382	CcSEcCtD
Ondansetron—OPRM1—endocrine gland—germ cell cancer	0.000687	0.00363	CbGeAlD
Ondansetron—Malaise—Bleomycin—germ cell cancer	0.000683	0.00378	CcSEcCtD
Ondansetron—OPRM1—head—germ cell cancer	0.000678	0.00358	CbGeAlD
Ondansetron—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000675	0.00374	CcSEcCtD
Ondansetron—Angiopathy—Ifosfamide—germ cell cancer	0.000674	0.00373	CcSEcCtD
Ondansetron—Immune system disorder—Ifosfamide—germ cell cancer	0.000671	0.00371	CcSEcCtD
Ondansetron—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00067	0.00371	CcSEcCtD
Ondansetron—Chills—Ifosfamide—germ cell cancer	0.000667	0.00369	CcSEcCtD
Ondansetron—Arrhythmia—Ifosfamide—germ cell cancer	0.000664	0.00367	CcSEcCtD
Ondansetron—Cough—Bleomycin—germ cell cancer	0.000661	0.00366	CcSEcCtD
Ondansetron—Paraesthesia—Vinblastine—germ cell cancer	0.000657	0.00363	CcSEcCtD
Ondansetron—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000655	0.00363	CcSEcCtD
Ondansetron—OPRM1—testis—germ cell cancer	0.000655	0.00346	CbGeAlD
Ondansetron—Bradycardia—Cisplatin—germ cell cancer	0.000652	0.00361	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000648	0.00359	CcSEcCtD
Ondansetron—SLC47A1—cerebellum—germ cell cancer	0.000648	0.00342	CbGeAlD
Ondansetron—Erythema—Ifosfamide—germ cell cancer	0.000647	0.00358	CcSEcCtD
Ondansetron—Acute coronary syndrome—Etoposide—germ cell cancer	0.000645	0.00357	CcSEcCtD
Ondansetron—Chest pain—Bleomycin—germ cell cancer	0.000645	0.00357	CcSEcCtD
Ondansetron—Myocardial infarction—Etoposide—germ cell cancer	0.000641	0.00355	CcSEcCtD
Ondansetron—Discomfort—Bleomycin—germ cell cancer	0.000637	0.00352	CcSEcCtD
Ondansetron—Malaise—Dactinomycin—germ cell cancer	0.000637	0.00352	CcSEcCtD
Ondansetron—HTR1B—endocrine gland—germ cell cancer	0.000628	0.00332	CbGeAlD
Ondansetron—Pain—Vinblastine—germ cell cancer	0.000626	0.00346	CcSEcCtD
Ondansetron—Constipation—Vinblastine—germ cell cancer	0.000626	0.00346	CcSEcCtD
Ondansetron—HTR1B—head—germ cell cancer	0.00062	0.00328	CbGeAlD
Ondansetron—Hepatobiliary disease—Etoposide—germ cell cancer	0.000619	0.00342	CcSEcCtD
Ondansetron—Anaphylactic shock—Bleomycin—germ cell cancer	0.000618	0.00342	CcSEcCtD
Ondansetron—Visual impairment—Cisplatin—germ cell cancer	0.000618	0.00342	CcSEcCtD
Ondansetron—Vision blurred—Ifosfamide—germ cell cancer	0.00061	0.00337	CcSEcCtD
Ondansetron—Feeling abnormal—Vinblastine—germ cell cancer	0.000603	0.00334	CcSEcCtD
Ondansetron—Ill-defined disorder—Ifosfamide—germ cell cancer	0.0006	0.00332	CcSEcCtD
Ondansetron—Eye disorder—Cisplatin—germ cell cancer	0.000599	0.00331	CcSEcCtD
Ondansetron—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000598	0.00331	CcSEcCtD
Ondansetron—Cardiac disorder—Cisplatin—germ cell cancer	0.000595	0.00329	CcSEcCtD
Ondansetron—Flushing—Cisplatin—germ cell cancer	0.000595	0.00329	CcSEcCtD
Ondansetron—Agitation—Ifosfamide—germ cell cancer	0.000595	0.00329	CcSEcCtD
Ondansetron—Discomfort—Dactinomycin—germ cell cancer	0.000594	0.00329	CcSEcCtD
Ondansetron—KCNH2—uterus—germ cell cancer	0.000593	0.00313	CbGeAlD
Ondansetron—Angioedema—Ifosfamide—germ cell cancer	0.000591	0.00327	CcSEcCtD
Ondansetron—HTR1A—adrenal gland—germ cell cancer	0.000585	0.00309	CbGeAlD
Ondansetron—Malaise—Ifosfamide—germ cell cancer	0.000584	0.00323	CcSEcCtD
Ondansetron—KCNH2—pituitary gland—germ cell cancer	0.000583	0.00308	CbGeAlD
Ondansetron—Immune system disorder—Cisplatin—germ cell cancer	0.000579	0.0032	CcSEcCtD
Ondansetron—Abdominal pain—Vinblastine—germ cell cancer	0.000578	0.0032	CcSEcCtD
Ondansetron—Mediastinal disorder—Cisplatin—germ cell cancer	0.000578	0.0032	CcSEcCtD
Ondansetron—Hypotension—Bleomycin—germ cell cancer	0.000577	0.00319	CcSEcCtD
Ondansetron—HTR1A—midbrain—germ cell cancer	0.000577	0.00305	CbGeAlD
Ondansetron—Arrhythmia—Cisplatin—germ cell cancer	0.000573	0.00317	CcSEcCtD
Ondansetron—Palpitations—Ifosfamide—germ cell cancer	0.000572	0.00316	CcSEcCtD
Ondansetron—Hepatic failure—Methotrexate—germ cell cancer	0.000566	0.00313	CcSEcCtD
Ondansetron—Cough—Ifosfamide—germ cell cancer	0.000565	0.00312	CcSEcCtD
Ondansetron—HTR1A—spinal cord—germ cell cancer	0.000563	0.00298	CbGeAlD
Ondansetron—KCNH2—medulla oblongata—germ cell cancer	0.000562	0.00297	CbGeAlD
Ondansetron—Convulsion—Ifosfamide—germ cell cancer	0.000561	0.0031	CcSEcCtD
Ondansetron—Erythema—Cisplatin—germ cell cancer	0.000558	0.00309	CcSEcCtD
Ondansetron—Erythema multiforme—Etoposide—germ cell cancer	0.000555	0.00307	CcSEcCtD
Ondansetron—Paraesthesia—Bleomycin—germ cell cancer	0.000555	0.00307	CcSEcCtD
Ondansetron—CYP2E1—telencephalon—germ cell cancer	0.000551	0.00291	CbGeAlD
Ondansetron—Dyspnoea—Bleomycin—germ cell cancer	0.000551	0.00305	CcSEcCtD
Ondansetron—Chest pain—Ifosfamide—germ cell cancer	0.000551	0.00305	CcSEcCtD
Ondansetron—Flatulence—Cisplatin—germ cell cancer	0.00055	0.00304	CcSEcCtD
Ondansetron—Eye disorder—Etoposide—germ cell cancer	0.000549	0.00304	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000547	0.00303	CcSEcCtD
Ondansetron—Flushing—Etoposide—germ cell cancer	0.000545	0.00301	CcSEcCtD
Ondansetron—Cardiac disorder—Etoposide—germ cell cancer	0.000545	0.00301	CcSEcCtD
Ondansetron—Discomfort—Ifosfamide—germ cell cancer	0.000544	0.00301	CcSEcCtD
Ondansetron—Hypersensitivity—Vinblastine—germ cell cancer	0.000539	0.00298	CcSEcCtD
Ondansetron—Visual disturbance—Methotrexate—germ cell cancer	0.000536	0.00297	CcSEcCtD
Ondansetron—HTR3A—brain—germ cell cancer	0.000536	0.00283	CbGeAlD
Ondansetron—Angiopathy—Etoposide—germ cell cancer	0.000533	0.00295	CcSEcCtD
Ondansetron—Immune system disorder—Etoposide—germ cell cancer	0.00053	0.00293	CcSEcCtD
Ondansetron—Mediastinal disorder—Etoposide—germ cell cancer	0.000529	0.00293	CcSEcCtD
Ondansetron—Pain—Bleomycin—germ cell cancer	0.000528	0.00292	CcSEcCtD
Ondansetron—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000528	0.00292	CcSEcCtD
Ondansetron—Chills—Etoposide—germ cell cancer	0.000527	0.00291	CcSEcCtD
Ondansetron—SLC47A1—brain—germ cell cancer	0.000526	0.00278	CbGeAlD
Ondansetron—Vision blurred—Cisplatin—germ cell cancer	0.000526	0.00291	CcSEcCtD
Ondansetron—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000525	0.00291	CcSEcCtD
Ondansetron—Asthenia—Vinblastine—germ cell cancer	0.000525	0.0029	CcSEcCtD
Ondansetron—Tremor—Cisplatin—germ cell cancer	0.000523	0.00289	CcSEcCtD
Ondansetron—KCNH2—adrenal gland—germ cell cancer	0.000521	0.00275	CbGeAlD
Ondansetron—Nervous system disorder—Ifosfamide—germ cell cancer	0.000518	0.00287	CcSEcCtD
Ondansetron—Ill-defined disorder—Cisplatin—germ cell cancer	0.000518	0.00286	CcSEcCtD
Ondansetron—KCNH2—midbrain—germ cell cancer	0.000514	0.00271	CbGeAlD
Ondansetron—Skin disorder—Ifosfamide—germ cell cancer	0.000513	0.00284	CcSEcCtD
Ondansetron—Feeling abnormal—Bleomycin—germ cell cancer	0.000509	0.00282	CcSEcCtD
Ondansetron—SLC47A1—lymph node—germ cell cancer	0.000509	0.00269	CbGeAlD
Ondansetron—HTR1A—endocrine gland—germ cell cancer	0.000507	0.00268	CbGeAlD
Ondansetron—KCNH2—bone marrow—germ cell cancer	0.000504	0.00266	CbGeAlD
Ondansetron—Malaise—Cisplatin—germ cell cancer	0.000503	0.00278	CcSEcCtD
Ondansetron—KCNH2—spinal cord—germ cell cancer	0.000501	0.00265	CbGeAlD
Ondansetron—Diarrhoea—Vinblastine—germ cell cancer	0.000501	0.00277	CcSEcCtD
Ondansetron—HTR1A—head—germ cell cancer	0.000501	0.00264	CbGeAlD
Ondansetron—Fatigue—Dactinomycin—germ cell cancer	0.000497	0.00275	CcSEcCtD
Ondansetron—Hypotension—Ifosfamide—germ cell cancer	0.000493	0.00273	CcSEcCtD
Ondansetron—Pain—Dactinomycin—germ cell cancer	0.000493	0.00273	CcSEcCtD
Ondansetron—CYP2D6—brainstem—germ cell cancer	0.000492	0.0026	CbGeAlD
Ondansetron—OPRM1—brain—germ cell cancer	0.000491	0.00259	CbGeAlD
Ondansetron—Urticaria—Bleomycin—germ cell cancer	0.000491	0.00272	CcSEcCtD
Ondansetron—Body temperature increased—Bleomycin—germ cell cancer	0.000489	0.0027	CcSEcCtD
Ondansetron—KCNH2—female gonad—germ cell cancer	0.000485	0.00256	CbGeAlD
Ondansetron—Dizziness—Vinblastine—germ cell cancer	0.000484	0.00268	CcSEcCtD
Ondansetron—Convulsion—Cisplatin—germ cell cancer	0.000483	0.00267	CcSEcCtD
Ondansetron—Feeling abnormal—Dactinomycin—germ cell cancer	0.000475	0.00263	CcSEcCtD
Ondansetron—Paraesthesia—Ifosfamide—germ cell cancer	0.000474	0.00262	CcSEcCtD
Ondansetron—Ill-defined disorder—Etoposide—germ cell cancer	0.000474	0.00262	CcSEcCtD
Ondansetron—Anxiety—Cisplatin—germ cell cancer	0.000473	0.00262	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000472	0.00261	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000471	0.00261	CcSEcCtD
Ondansetron—Dyspnoea—Ifosfamide—germ cell cancer	0.000471	0.00261	CcSEcCtD
Ondansetron—Somnolence—Ifosfamide—germ cell cancer	0.00047	0.0026	CcSEcCtD
Ondansetron—Liver function test abnormal—Methotrexate—germ cell cancer	0.000469	0.0026	CcSEcCtD
Ondansetron—Discomfort—Cisplatin—germ cell cancer	0.000469	0.0026	CcSEcCtD
Ondansetron—Vomiting—Vinblastine—germ cell cancer	0.000465	0.00257	CcSEcCtD
Ondansetron—Malaise—Etoposide—germ cell cancer	0.000461	0.00255	CcSEcCtD
Ondansetron—Headache—Vinblastine—germ cell cancer	0.000458	0.00254	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000458	0.00253	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000456	0.00252	CcSEcCtD
Ondansetron—Abdominal pain—Dactinomycin—germ cell cancer	0.000456	0.00252	CcSEcCtD
Ondansetron—Body temperature increased—Dactinomycin—germ cell cancer	0.000456	0.00252	CcSEcCtD
Ondansetron—Fatigue—Ifosfamide—germ cell cancer	0.000455	0.00252	CcSEcCtD
Ondansetron—Anaphylactic shock—Cisplatin—germ cell cancer	0.000455	0.00252	CcSEcCtD
Ondansetron—Hypersensitivity—Bleomycin—germ cell cancer	0.000455	0.00252	CcSEcCtD
Ondansetron—Constipation—Ifosfamide—germ cell cancer	0.000452	0.0025	CcSEcCtD
Ondansetron—Pain—Ifosfamide—germ cell cancer	0.000452	0.0025	CcSEcCtD
Ondansetron—KCNH2—endocrine gland—germ cell cancer	0.000451	0.00238	CbGeAlD
Ondansetron—HTR1B—brain—germ cell cancer	0.00045	0.00237	CbGeAlD
Ondansetron—Loss of consciousness—Etoposide—germ cell cancer	0.000449	0.00249	CcSEcCtD
Ondansetron—HTR1A—cerebellum—germ cell cancer	0.000447	0.00236	CbGeAlD
Ondansetron—Nervous system disorder—Cisplatin—germ cell cancer	0.000447	0.00247	CcSEcCtD
Ondansetron—Cough—Etoposide—germ cell cancer	0.000446	0.00247	CcSEcCtD
Ondansetron—KCNH2—head—germ cell cancer	0.000446	0.00235	CbGeAlD
Ondansetron—Tachycardia—Cisplatin—germ cell cancer	0.000444	0.00246	CcSEcCtD
Ondansetron—Asthenia—Bleomycin—germ cell cancer	0.000443	0.00245	CcSEcCtD
Ondansetron—Convulsion—Etoposide—germ cell cancer	0.000443	0.00245	CcSEcCtD
Ondansetron—Skin disorder—Cisplatin—germ cell cancer	0.000442	0.00245	CcSEcCtD
Ondansetron—Asthma—Methotrexate—germ cell cancer	0.000439	0.00243	CcSEcCtD
Ondansetron—Pruritus—Bleomycin—germ cell cancer	0.000437	0.00242	CcSEcCtD
Ondansetron—CYP2D6—telencephalon—germ cell cancer	0.000436	0.00231	CbGeAlD
Ondansetron—Feeling abnormal—Ifosfamide—germ cell cancer	0.000435	0.00241	CcSEcCtD
Ondansetron—Chest pain—Etoposide—germ cell cancer	0.000435	0.00241	CcSEcCtD
Ondansetron—CYP2E1—medulla oblongata—germ cell cancer	0.000433	0.00229	CbGeAlD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000432	0.00239	CcSEcCtD
Ondansetron—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000432	0.00239	CcSEcCtD
Ondansetron—KCNH2—testis—germ cell cancer	0.00043	0.00227	CbGeAlD
Ondansetron—Discomfort—Etoposide—germ cell cancer	0.00043	0.00238	CcSEcCtD
Ondansetron—Hypotension—Cisplatin—germ cell cancer	0.000425	0.00235	CcSEcCtD
Ondansetron—Hypersensitivity—Dactinomycin—germ cell cancer	0.000425	0.00235	CcSEcCtD
Ondansetron—Urticaria—Ifosfamide—germ cell cancer	0.00042	0.00232	CcSEcCtD
Ondansetron—Abdominal pain—Ifosfamide—germ cell cancer	0.000417	0.00231	CcSEcCtD
Ondansetron—Body temperature increased—Ifosfamide—germ cell cancer	0.000417	0.00231	CcSEcCtD
Ondansetron—Anaphylactic shock—Etoposide—germ cell cancer	0.000417	0.00231	CcSEcCtD
Ondansetron—Asthenia—Dactinomycin—germ cell cancer	0.000413	0.00229	CcSEcCtD
Ondansetron—Dysuria—Methotrexate—germ cell cancer	0.000411	0.00227	CcSEcCtD
Ondansetron—Paraesthesia—Cisplatin—germ cell cancer	0.000409	0.00226	CcSEcCtD
Ondansetron—Tachycardia—Etoposide—germ cell cancer	0.000407	0.00225	CcSEcCtD
Ondansetron—Dyspnoea—Cisplatin—germ cell cancer	0.000406	0.00225	CcSEcCtD
Ondansetron—Skin disorder—Etoposide—germ cell cancer	0.000405	0.00224	CcSEcCtD
Ondansetron—CYP2E1—adrenal gland—germ cell cancer	0.000401	0.00212	CbGeAlD
Ondansetron—CYP3A5—female gonad—germ cell cancer	0.000401	0.00212	CbGeAlD
Ondansetron—KCNH2—cerebellum—germ cell cancer	0.000398	0.0021	CbGeAlD
Ondansetron—Diarrhoea—Dactinomycin—germ cell cancer	0.000394	0.00218	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000393	0.00217	CcSEcCtD
Ondansetron—Vomiting—Bleomycin—germ cell cancer	0.000393	0.00217	CcSEcCtD
Ondansetron—Drowsiness—Methotrexate—germ cell cancer	0.000392	0.00217	CcSEcCtD
Ondansetron—Hypotension—Etoposide—germ cell cancer	0.00039	0.00216	CcSEcCtD
Ondansetron—Rash—Bleomycin—germ cell cancer	0.00039	0.00216	CcSEcCtD
Ondansetron—Pain—Cisplatin—germ cell cancer	0.000389	0.00215	CcSEcCtD
Ondansetron—Dermatitis—Bleomycin—germ cell cancer	0.000389	0.00215	CcSEcCtD
Ondansetron—Hypersensitivity—Ifosfamide—germ cell cancer	0.000389	0.00215	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000388	0.00215	CcSEcCtD
Ondansetron—CYP1A2—endocrine gland—germ cell cancer	0.000386	0.00204	CbGeAlD
Ondansetron—CYP2E1—spinal cord—germ cell cancer	0.000386	0.00204	CbGeAlD
Ondansetron—Asthenia—Ifosfamide—germ cell cancer	0.000379	0.0021	CcSEcCtD
Ondansetron—Feeling abnormal—Cisplatin—germ cell cancer	0.000375	0.00208	CcSEcCtD
Ondansetron—Paraesthesia—Etoposide—germ cell cancer	0.000375	0.00207	CcSEcCtD
Ondansetron—Pruritus—Ifosfamide—germ cell cancer	0.000374	0.00207	CcSEcCtD
Ondansetron—CYP3A5—endocrine gland—germ cell cancer	0.000373	0.00197	CbGeAlD
Ondansetron—Dyspnoea—Etoposide—germ cell cancer	0.000372	0.00206	CcSEcCtD
Ondansetron—Somnolence—Etoposide—germ cell cancer	0.000371	0.00205	CcSEcCtD
Ondansetron—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00037	0.00205	CcSEcCtD
Ondansetron—CYP2C9—endocrine gland—germ cell cancer	0.000367	0.00194	CbGeAlD
Ondansetron—Vomiting—Dactinomycin—germ cell cancer	0.000366	0.00203	CcSEcCtD
Ondansetron—Rash—Dactinomycin—germ cell cancer	0.000363	0.00201	CcSEcCtD
Ondansetron—HTR1A—brain—germ cell cancer	0.000363	0.00192	CbGeAlD
Ondansetron—Diarrhoea—Ifosfamide—germ cell cancer	0.000361	0.002	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00036	0.00199	CcSEcCtD
Ondansetron—Body temperature increased—Cisplatin—germ cell cancer	0.00036	0.00199	CcSEcCtD
Ondansetron—Fatigue—Etoposide—germ cell cancer	0.00036	0.00199	CcSEcCtD
Ondansetron—Constipation—Etoposide—germ cell cancer	0.000357	0.00197	CcSEcCtD
Ondansetron—Pain—Etoposide—germ cell cancer	0.000357	0.00197	CcSEcCtD
Ondansetron—Haemoglobin—Methotrexate—germ cell cancer	0.000353	0.00196	CcSEcCtD
Ondansetron—Haemorrhage—Methotrexate—germ cell cancer	0.000352	0.00195	CcSEcCtD
Ondansetron—Dizziness—Ifosfamide—germ cell cancer	0.000349	0.00193	CcSEcCtD
Ondansetron—CYP2E1—endocrine gland—germ cell cancer	0.000348	0.00184	CbGeAlD
Ondansetron—Feeling abnormal—Etoposide—germ cell cancer	0.000344	0.0019	CcSEcCtD
Ondansetron—CYP2E1—head—germ cell cancer	0.000343	0.00181	CbGeAlD
Ondansetron—Gastrointestinal pain—Etoposide—germ cell cancer	0.000341	0.00189	CcSEcCtD
Ondansetron—Visual impairment—Methotrexate—germ cell cancer	0.000339	0.00188	CcSEcCtD
Ondansetron—Vomiting—Ifosfamide—germ cell cancer	0.000336	0.00186	CcSEcCtD
Ondansetron—Hypersensitivity—Cisplatin—germ cell cancer	0.000335	0.00186	CcSEcCtD
Ondansetron—Rash—Ifosfamide—germ cell cancer	0.000333	0.00184	CcSEcCtD
Ondansetron—Dermatitis—Ifosfamide—germ cell cancer	0.000333	0.00184	CcSEcCtD
Ondansetron—Erythema multiforme—Methotrexate—germ cell cancer	0.000333	0.00184	CcSEcCtD
Ondansetron—CYP2E1—testis—germ cell cancer	0.000332	0.00175	CbGeAlD
Ondansetron—Urticaria—Etoposide—germ cell cancer	0.000331	0.00183	CcSEcCtD
Ondansetron—Body temperature increased—Etoposide—germ cell cancer	0.00033	0.00182	CcSEcCtD
Ondansetron—Abdominal pain—Etoposide—germ cell cancer	0.00033	0.00182	CcSEcCtD
Ondansetron—Eye disorder—Methotrexate—germ cell cancer	0.000329	0.00182	CcSEcCtD
Ondansetron—Asthenia—Cisplatin—germ cell cancer	0.000327	0.00181	CcSEcCtD
Ondansetron—Cardiac disorder—Methotrexate—germ cell cancer	0.000326	0.00181	CcSEcCtD
Ondansetron—KCNH2—brain—germ cell cancer	0.000323	0.00171	CbGeAlD
Ondansetron—Angiopathy—Methotrexate—germ cell cancer	0.000319	0.00177	CcSEcCtD
Ondansetron—Immune system disorder—Methotrexate—germ cell cancer	0.000318	0.00176	CcSEcCtD
Ondansetron—Mediastinal disorder—Methotrexate—germ cell cancer	0.000317	0.00175	CcSEcCtD
Ondansetron—Chills—Methotrexate—germ cell cancer	0.000316	0.00175	CcSEcCtD
Ondansetron—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000315	0.0623	CbGpPWpGaD
Ondansetron—KCNH2—lymph node—germ cell cancer	0.000312	0.00165	CbGeAlD
Ondansetron—Diarrhoea—Cisplatin—germ cell cancer	0.000312	0.00172	CcSEcCtD
Ondansetron—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000311	0.0614	CbGpPWpGaD
Ondansetron—Hypersensitivity—Etoposide—germ cell cancer	0.000307	0.0017	CcSEcCtD
Ondansetron—CYP2E1—cerebellum—germ cell cancer	0.000306	0.00162	CbGeAlD
Ondansetron—Erythema—Methotrexate—germ cell cancer	0.000306	0.00169	CcSEcCtD
Ondansetron—Asthenia—Etoposide—germ cell cancer	0.000299	0.00166	CcSEcCtD
Ondansetron—CYP2D6—female gonad—germ cell cancer	0.000296	0.00156	CbGeAlD
Ondansetron—Pruritus—Etoposide—germ cell cancer	0.000295	0.00163	CcSEcCtD
Ondansetron—Vomiting—Cisplatin—germ cell cancer	0.000289	0.0016	CcSEcCtD
Ondansetron—Vision blurred—Methotrexate—germ cell cancer	0.000289	0.0016	CcSEcCtD
Ondansetron—Rash—Cisplatin—germ cell cancer	0.000287	0.00159	CcSEcCtD
Ondansetron—Dermatitis—Cisplatin—germ cell cancer	0.000287	0.00159	CcSEcCtD
Ondansetron—Diarrhoea—Etoposide—germ cell cancer	0.000285	0.00158	CcSEcCtD
Ondansetron—Ill-defined disorder—Methotrexate—germ cell cancer	0.000284	0.00157	CcSEcCtD
Ondansetron—CYP3A4—endocrine gland—germ cell cancer	0.00028	0.00148	CbGeAlD
Ondansetron—Malaise—Methotrexate—germ cell cancer	0.000276	0.00153	CcSEcCtD
Ondansetron—Dizziness—Etoposide—germ cell cancer	0.000276	0.00153	CcSEcCtD
Ondansetron—CYP2D6—endocrine gland—germ cell cancer	0.000275	0.00145	CbGeAlD
Ondansetron—CYP2D6—head—germ cell cancer	0.000272	0.00144	CbGeAlD
Ondansetron—Cough—Methotrexate—germ cell cancer	0.000267	0.00148	CcSEcCtD
Ondansetron—Convulsion—Methotrexate—germ cell cancer	0.000265	0.00147	CcSEcCtD
Ondansetron—Vomiting—Etoposide—germ cell cancer	0.000265	0.00147	CcSEcCtD
Ondansetron—Rash—Etoposide—germ cell cancer	0.000263	0.00146	CcSEcCtD
Ondansetron—Dermatitis—Etoposide—germ cell cancer	0.000263	0.00145	CcSEcCtD
Ondansetron—CYP2D6—testis—germ cell cancer	0.000263	0.00139	CbGeAlD
Ondansetron—Headache—Etoposide—germ cell cancer	0.000261	0.00145	CcSEcCtD
Ondansetron—Chest pain—Methotrexate—germ cell cancer	0.000261	0.00144	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000259	0.00143	CcSEcCtD
Ondansetron—Discomfort—Methotrexate—germ cell cancer	0.000258	0.00142	CcSEcCtD
Ondansetron—Anaphylactic shock—Methotrexate—germ cell cancer	0.00025	0.00138	CcSEcCtD
Ondansetron—CYP2E1—brain—germ cell cancer	0.000249	0.00131	CbGeAlD
Ondansetron—Nervous system disorder—Methotrexate—germ cell cancer	0.000245	0.00136	CcSEcCtD
Ondansetron—Skin disorder—Methotrexate—germ cell cancer	0.000243	0.00134	CcSEcCtD
Ondansetron—CYP2D6—cerebellum—germ cell cancer	0.000242	0.00128	CbGeAlD
Ondansetron—Hypotension—Methotrexate—germ cell cancer	0.000233	0.00129	CcSEcCtD
Ondansetron—Paraesthesia—Methotrexate—germ cell cancer	0.000224	0.00124	CcSEcCtD
Ondansetron—Dyspnoea—Methotrexate—germ cell cancer	0.000223	0.00123	CcSEcCtD
Ondansetron—Somnolence—Methotrexate—germ cell cancer	0.000222	0.00123	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000216	0.00119	CcSEcCtD
Ondansetron—Fatigue—Methotrexate—germ cell cancer	0.000215	0.00119	CcSEcCtD
Ondansetron—Pain—Methotrexate—germ cell cancer	0.000214	0.00118	CcSEcCtD
Ondansetron—Feeling abnormal—Methotrexate—germ cell cancer	0.000206	0.00114	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000204	0.00113	CcSEcCtD
Ondansetron—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000203	0.0401	CbGpPWpGaD
Ondansetron—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.0002	0.0395	CbGpPWpGaD
Ondansetron—Urticaria—Methotrexate—germ cell cancer	0.000198	0.0011	CcSEcCtD
Ondansetron—Abdominal pain—Methotrexate—germ cell cancer	0.000198	0.00109	CcSEcCtD
Ondansetron—Body temperature increased—Methotrexate—germ cell cancer	0.000198	0.00109	CcSEcCtD
Ondansetron—CYP2D6—brain—germ cell cancer	0.000197	0.00104	CbGeAlD
Ondansetron—Hypersensitivity—Methotrexate—germ cell cancer	0.000184	0.00102	CcSEcCtD
Ondansetron—Asthenia—Methotrexate—germ cell cancer	0.000179	0.000992	CcSEcCtD
Ondansetron—Pruritus—Methotrexate—germ cell cancer	0.000177	0.000978	CcSEcCtD
Ondansetron—Diarrhoea—Methotrexate—germ cell cancer	0.000171	0.000946	CcSEcCtD
Ondansetron—Dizziness—Methotrexate—germ cell cancer	0.000165	0.000914	CcSEcCtD
Ondansetron—Vomiting—Methotrexate—germ cell cancer	0.000159	0.000879	CcSEcCtD
Ondansetron—Rash—Methotrexate—germ cell cancer	0.000158	0.000872	CcSEcCtD
Ondansetron—Dermatitis—Methotrexate—germ cell cancer	0.000157	0.000871	CcSEcCtD
Ondansetron—Headache—Methotrexate—germ cell cancer	0.000157	0.000866	CcSEcCtD
Ondansetron—HTR3A—Ion channel transport—SCNN1A—germ cell cancer	0.000156	0.0309	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000154	0.0305	CbGpPWpGaD
Ondansetron—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.000153	0.0303	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000149	0.0293	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000143	0.0283	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000141	0.0279	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000111	0.022	CbGpPWpGaD
Ondansetron—CYP2E1—Metapathway biotransformation—NAT9—germ cell cancer	0.000111	0.0219	CbGpPWpGaD
Ondansetron—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000111	0.0219	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000107	0.0211	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000103	0.0203	CbGpPWpGaD
Ondansetron—KCNH2—Hematopoietic Stem Cell Differentiation—KITLG—germ cell cancer	0.000102	0.0202	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	9.23e-05	0.0182	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.1e-05	0.018	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	8.24e-05	0.0163	CbGpPWpGaD
Ondansetron—HTR4—G alpha (s) signalling events—AVP—germ cell cancer	7.97e-05	0.0157	CbGpPWpGaD
Ondansetron—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	7.87e-05	0.0156	CbGpPWpGaD
Ondansetron—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	7.81e-05	0.0154	CbGpPWpGaD
Ondansetron—CYP2E1—Vitamin A and Carotenoid Metabolism—CRABP1—germ cell cancer	7.44e-05	0.0147	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.28e-05	0.0144	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.17e-05	0.0142	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.17e-05	0.0142	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	6.71e-05	0.0133	CbGpPWpGaD
Ondansetron—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	6.67e-05	0.0132	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.61e-05	0.0131	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	6.46e-05	0.0128	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	5.71e-05	0.0113	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.55e-05	0.011	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.44e-05	0.0107	CbGpPWpGaD
Ondansetron—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	5.15e-05	0.0102	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—AVP—germ cell cancer	4.86e-05	0.00959	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.69e-05	0.00927	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.62e-05	0.00913	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.26e-05	0.00841	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—OXT—germ cell cancer	4.22e-05	0.00834	CbGpPWpGaD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	3.8e-05	0.00751	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	3.58e-05	0.00708	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.56e-05	0.00702	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.5e-05	0.00692	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—AVP—germ cell cancer	3.37e-05	0.00665	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.36e-05	0.00663	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—OXT—germ cell cancer	3.05e-05	0.00602	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—AVP—germ cell cancer	2.89e-05	0.00572	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—OXT—germ cell cancer	2.39e-05	0.00471	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	2.32e-05	0.00458	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—OXT—germ cell cancer	2.17e-05	0.00428	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.16e-05	0.00427	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—AVP—germ cell cancer	2.11e-05	0.00417	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—AVP—germ cell cancer	2.09e-05	0.00413	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	2.05e-05	0.00404	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	1.77e-05	0.00349	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—OXT—germ cell cancer	1.76e-05	0.00349	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—AVP—germ cell cancer	1.64e-05	0.00324	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—AVP—germ cell cancer	1.64e-05	0.00323	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	1.59e-05	0.00314	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—OXT—germ cell cancer	1.56e-05	0.00308	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—AVP—germ cell cancer	1.49e-05	0.00293	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	1.4e-05	0.00277	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—OXT—germ cell cancer	1.34e-05	0.00266	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—OXT—germ cell cancer	1.28e-05	0.00253	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	1.21e-05	0.00239	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—AVP—germ cell cancer	1.21e-05	0.00239	CbGpPWpGaD
Ondansetron—OPRM1—TCR Signaling Pathway—HRAS—germ cell cancer	1.15e-05	0.00226	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—FGF4—germ cell cancer	1.09e-05	0.00216	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—AVP—germ cell cancer	1.07e-05	0.00211	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—OXT—germ cell cancer	9.97e-06	0.00197	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—H2AFZ—germ cell cancer	9.76e-06	0.00193	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	9.35e-06	0.00185	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—AVP—germ cell cancer	9.21e-06	0.00182	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—OXT—germ cell cancer	9.06e-06	0.00179	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—KITLG—germ cell cancer	8.98e-06	0.00177	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—OXT—germ cell cancer	8.8e-06	0.00174	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—AVP—germ cell cancer	8.78e-06	0.00173	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—OXT—germ cell cancer	7.99e-06	0.00158	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—OXT—germ cell cancer	7.6e-06	0.0015	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	7.34e-06	0.00145	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SLC2A3—germ cell cancer	7.22e-06	0.00143	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SLC22A3—germ cell cancer	7.11e-06	0.0014	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—OXT—germ cell cancer	6.9e-06	0.00136	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AVP—germ cell cancer	6.83e-06	0.00135	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—FGFR3—germ cell cancer	6.67e-06	0.00132	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.63e-06	0.00131	CbGpPWpGaD
Ondansetron—KCNH2—Neuronal System—HRAS—germ cell cancer	6.38e-06	0.00126	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AVP—germ cell cancer	6.21e-06	0.00123	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—KIT—germ cell cancer	6.13e-06	0.00121	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AVP—germ cell cancer	6.03e-06	0.00119	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CRABP1—germ cell cancer	5.79e-06	0.00114	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.67e-06	0.00112	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AVP—germ cell cancer	5.48e-06	0.00108	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—OXT—germ cell cancer	5.35e-06	0.00106	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SLC2A3—germ cell cancer	5.23e-06	0.00103	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SLC2A3—germ cell cancer	5.22e-06	0.00103	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AVP—germ cell cancer	5.21e-06	0.00103	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SLC22A3—germ cell cancer	5.15e-06	0.00102	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SLC22A3—germ cell cancer	5.14e-06	0.00101	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AVP—germ cell cancer	4.73e-06	0.000934	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—OXT—germ cell cancer	4.72e-06	0.000933	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGF4—germ cell cancer	4.57e-06	0.000902	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—HRAS—germ cell cancer	4.48e-06	0.000885	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CRABP1—germ cell cancer	4.2e-06	0.000829	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CRABP1—germ cell cancer	4.19e-06	0.000827	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—H2AFZ—germ cell cancer	4.08e-06	0.000805	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—OXT—germ cell cancer	4.08e-06	0.000805	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGF4—germ cell cancer	4.03e-06	0.000796	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—KITLG—germ cell cancer	3.75e-06	0.000741	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC2A3—germ cell cancer	3.71e-06	0.000733	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC2A3—germ cell cancer	3.68e-06	0.000726	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AVP—germ cell cancer	3.67e-06	0.000724	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC22A3—germ cell cancer	3.65e-06	0.000722	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC22A3—germ cell cancer	3.62e-06	0.000715	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—H2AFZ—germ cell cancer	3.6e-06	0.000711	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGF4—germ cell cancer	3.48e-06	0.000687	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MYC—germ cell cancer	3.37e-06	0.000666	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—KITLG—germ cell cancer	3.31e-06	0.000654	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AVP—germ cell cancer	3.24e-06	0.000639	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC2A3—germ cell cancer	3.14e-06	0.000621	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—H2AFZ—germ cell cancer	3.11e-06	0.000614	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC22A3—germ cell cancer	3.1e-06	0.000611	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CRABP1—germ cell cancer	2.98e-06	0.000588	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CRABP1—germ cell cancer	2.95e-06	0.000583	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KITLG—germ cell cancer	2.86e-06	0.000564	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AVP—germ cell cancer	2.79e-06	0.000552	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGFR3—germ cell cancer	2.79e-06	0.000551	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TP53—germ cell cancer	2.77e-06	0.000547	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—HRAS—germ cell cancer	2.65e-06	0.000523	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—KIT—germ cell cancer	2.56e-06	0.000506	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CRABP1—germ cell cancer	2.52e-06	0.000498	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGFR3—germ cell cancer	2.46e-06	0.000486	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.43e-06	0.000479	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.39e-06	0.000472	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—KIT—germ cell cancer	2.26e-06	0.000446	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGFR3—germ cell cancer	2.12e-06	0.00042	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KIT—germ cell cancer	1.95e-06	0.000385	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.95e-06	0.000385	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—HRAS—germ cell cancer	1.87e-06	0.00037	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—HRAS—germ cell cancer	1.65e-06	0.000326	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—HRAS—germ cell cancer	1.43e-06	0.000282	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MYC—germ cell cancer	1.41e-06	0.000278	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MYC—germ cell cancer	1.24e-06	0.000246	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TP53—germ cell cancer	1.16e-06	0.000228	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—HRAS—germ cell cancer	1.11e-06	0.000219	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MYC—germ cell cancer	1.07e-06	0.000212	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TP53—germ cell cancer	1.02e-06	0.000202	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—HRAS—germ cell cancer	9.76e-07	0.000193	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TP53—germ cell cancer	8.81e-07	0.000174	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—HRAS—germ cell cancer	8.43e-07	0.000166	CbGpPWpGaD
